California Investigating Antipsychotic Medication Marketing Practices
December 4, 2006 California Investigating Antipsychotic Medication Marketing Practices The California Attorney General is investigating marketing practices for antipsychotic medications to determine the effects on the Medi-Cal formulary. According to a November 3, 2006 report by MarketWatch, subpoenas have been issued to pharmaceutical manufacturers Eli Lilly, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb, and Pfizer. All of the manufacturers are responding to the states request for information. According to statements made by the manufacturers, the subpoenas are related to payments made to health care providers, general marketing practices and sales, and side effects of the medications. The following . . .